Debut Plus

₹586.45

▼ -15.47 -2.57%

17 Jul 2026

NSE Listed · FMCG

Zydus Wellness Limited (ZYDUSWELL)

Volume: 45,126Avg Vol 1W: 2,45,038Avg Vol 1M: 2,80,73052W Range:₹367.55₹608
NSE BSE www.zyduswellness.com
Key Ratios
Checked just now
Market Cap₹18,659 Cr
Current Price₹586.45
Previous Close₹601.92
High / Low (52w)₹608 / ₹367.55
Volume45,126
Avg Vol (1W)2,45,038
Avg Vol (1M)2,80,730
Stock P/E81.56
Book Value₹183.12
Dividend Yield20%
ROE398.4%
ROA191.31%
Revenue (TTM)—
Revenue Growth16.37%
Profit Margin5.01%
Total Debt₹0 Cr
Shares Outstanding32 Cr
Face Value₹2
EPS (TTM)₹7.19
P/B3.2
Debt / Equity0.29
50 DMA₹555.13
200 DMA₹487.47
Day change-2.57%
Price Chart
₹586.45▲ 30.74% · 1Y
₹602₹3744.8Cr
2025-11-24
2026-07-17

20-day avg volume: 2.7L shares

Pros
  • Healthy return on equity of 398.4%.
  • Pays a dividend yield of 20.0%.
  • Company is almost debt-free.
  • Revenue grew 46% YoY.
Cons
  • Stock trades at a high P/E of 82.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹841 Cr₹493 Cr₹462 Cr₹913 Cr₹861 Cr₹651 Cr₹965 Cr₹1,485 Cr
EBITDA₹155 Cr₹19 Cr₹13 Cr₹178 Cr₹148 Cr₹-1 Cr₹6 Cr₹216 Cr
Net Profit₹148 Cr₹21 Cr₹6 Cr₹172 Cr₹128 Cr₹-53 Cr₹-40 Cr₹162 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹882 Cr₹1,778 Cr₹1,876 Cr₹2,020 Cr₹2,260 Cr₹2,342 Cr₹2,723 Cr₹3,967 Cr
EBITDA₹211 Cr₹305 Cr₹328 Cr₹332 Cr₹317 Cr₹298 Cr₹365 Cr₹369 Cr
Net Profit₹169 Cr₹142 Cr₹119 Cr₹309 Cr₹310 Cr₹267 Cr₹347 Cr₹197 Cr
EPS40.124.5819.5548.5448.7841.9410.96.2
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹5,459 Cr₹5,590 Cr₹5,666 Cr₹5,692 Cr₹5,833 Cr₹6,148 Cr₹6,442 Cr₹10,308 Cr
Total Liabilities₹2,072 Cr₹2,129 Cr₹1,099 Cr₹848 Cr₹711 Cr₹791 Cr₹770 Cr₹4,482 Cr
Equity₹3,386 Cr₹3,461 Cr₹4,568 Cr₹4,844 Cr₹5,123 Cr₹5,358 Cr₹5,672 Cr₹5,826 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹212 Cr₹261 Cr₹287 Cr₹241 Cr₹93 Cr₹249 Cr₹377 Cr₹256 Cr
Investing₹-4,162 Cr₹-17 Cr₹-10 Cr₹-59 Cr₹-85 Cr₹-178 Cr₹-224 Cr₹-2,910 Cr
Financing₹4,052 Cr₹-260 Cr₹-216 Cr₹-234 Cr₹-138 Cr₹-26 Cr₹-186 Cr₹2,698 Cr
Free Cash Flow₹212 Cr₹261 Cr₹287 Cr₹241 Cr₹93 Cr₹249 Cr₹377 Cr₹256 Cr
Shareholding
Promoter 69.63% Institutions 22.05% Public 8.31%
Efficiency & Working Capital
ROCE4.1%
Interest Coverage3.7
Dividend Payout—
Debtor Days35 d
Inventory Days70 d
Payable Days43 d
Cash Conversion Cycle63 d
Working Capital Days106 d
Shareholding Details

As of 2026-03-31

Promoter69.6%
FII3.2%
DII18.9%
Institutions22.1%
Public8.3%
Promoter Pledge0%
No. of Shareholders80,671
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters67.1%68.5%69.2%69.6%69.6%69.6%69.6%69.6%69.6%69.6%69.6%69.6%
FIIs3.2%3.4%3.2%3.3%3.3%3.4%3.4%3.3%3.3%3.4%3.3%3.2%
DIIs10.7%20.2%9.4%19.4%19.4%20.4%20.1%19.8%19.3%18.8%18.6%18.9%
Public19%7.8%18.2%7.7%7.6%6.7%6.9%7.3%7.8%8.2%8.5%8.3%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders73,02976,59075,36969,13863,97360,98164,03764,97966,51477,18880,10580,671
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Zydus Lifesciences LimitedShareholding of Promoter and Promoter Group57.6%18.32 Cr
Zydus Family Trust(trustee:mr. Pankaj R. Patel,smt. Pritiben P. Patel, Dr. Sharvil P. Patel)Shareholding of Promoter and Promoter Group12%3.82 Cr
Parag Parikh Flexi Cap FundPublic Shareholding7.3%2.33 Cr
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap FundPublic Shareholding5.9%1.87 Cr
Quant Mutual Fund - Quant Small Cap FundPublic Shareholding4.3%1.38 Cr
Jasodaben Babubhai PatelShareholding of Promoter and Promoter Group0%37,250
Arati Rajiv Mehta Jointly With Rajiv Vastupal MehtaShareholding of Promoter and Promoter Group0%13,730
Ritaben Yatinbhai DesaiShareholding of Promoter and Promoter Group0%6,000
Ayushi Rajiv Mehta Jointly With Arati Rajiv MehtaShareholding of Promoter and Promoter Group0%3,200
Gira Vijay PatelShareholding of Promoter and Promoter Group0%0
Samar Babubhai PatelShareholding of Promoter and Promoter Group0%0
Prashant Babubhai PatelShareholding of Promoter and Promoter Group0%0
Meha Sharvil PatelShareholding of Promoter and Promoter Group0%0
Shaurya Sharvil PatelShareholding of Promoter and Promoter Group0%0
Veda Sharvil PatelShareholding of Promoter and Promoter Group0%0
Ketkiben Mukeshbhai PatelShareholding of Promoter and Promoter Group0%0
Sharvil P. Patel (huf,karta:mr. Sharvil P. Patel)Shareholding of Promoter and Promoter Group0%0
Pankajbhai Ramanbhai Patel(smallerhuf,karta:mr. Pankaj R. Patel)Shareholding of Promoter and Promoter Group0%0
Morgan Stanley Dean Witter Investment Management Inc Sub A/c Taj Investments LimitedPublic Shareholding0%135
Pankajbhai Ramanbhai PatelShareholding of Promoter and Promoter Group0%7,995
Pankajbhai Ramanbhai Patel(huf,karta:mr. Pankaj R. Patel)Shareholding of Promoter and Promoter Group0%5,330
Pritiben Pankajbhai PatelShareholding of Promoter and Promoter Group0%2,665
Sharvil Pankajbhai PatelShareholding of Promoter and Promoter Group0%2,665
Shivani Pankajbhai PatelShareholding of Promoter and Promoter Group0%3,005
Pripan Investment Private LimitedShareholding of Promoter and Promoter Group0%3,200
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Pankajbhai Ramanbhai Patel00%2026-06-30
Pankajbhai Ramanbhai Patel(huf,karta:mr. Pankaj R. Patel)00%2026-06-30
Pritiben Pankajbhai Patel00%2026-06-30
Sharvil Pankajbhai Patel00%2026-06-30
Shivani Pankajbhai Patel00%2026-06-30
Late Jasodaben Babubhai Patel00%2026-06-30
Arati Rajiv Mehta Jointly With Rajiv Vastupal Mehta00%2026-06-30
Ritaben Yatin Desai00%2026-06-30
Ayushi Rajiv Mehta Jointly With Arati Rajiv Mehta00%2026-06-30
Gira Vijay Patel00%2026-06-30
Prashant Babubhai Patel00%2026-06-30
Meha Sharvil Patel00%2026-06-30
Board of Directors
NameDesignationYear
Ganesh N NayakNon-Executive & Non-Independent Director2025
Sharvil P PatelChairman (Non-Executive)2025
Tarun AroraWhole Time Director & Chief Executive Officer2025
Kulin S LalbhaiNon Executive & Independent Director2025
Dharmishta N RawalNon Executive & Independent Director2025
Srivishnu Raju NandyalaNon Executive & Independent Director2025
Nandish P. JoshiCompany Sec. & Compli. Officer2025
Akhil A. MonappaNon Executive & Independent Director2025
A S DiwanjiAdditional Director2025
Segments — Product
SegmentRevenueShare
Consumer Products₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹21006464
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-04Board Meetings—
forthcoming2026-07-17Dividend (1.2/- per share)Final
dividend2026-07-17₹1.2 (60%)Final
split2025-09-181:5face value change from 10 to 2
dividend2025-07-11₹6 (60%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20257660044794
20254460000446
202553004481
Insider / Designated-Person Trades

30 recent disclosure(s)

Samar Babubhai PatelAcquisition · 1,000
Samar Babubhai PatelAcquisition · 500
Samar Babubhai PatelAcquisition · 500
Rupa Nitin ParekhAcquisition · 4,000
Samar Babubhai PatelAcquisition · 10,000
Rinesh GajjarAcquisition · 1,500
Substantial Acquisitions (SAST)

5 disclosure(s)

Block Deal06/08/2024 · 17,00,000
Market11/03/2024 · 1,86,353
Market23/02/2024 · 1,10,000
Block Deal28/12/2023 · 3,90,000
Block Deal28/12/2023 · 7,80,000
Company Information
Incorporated1994
ChairmanSharvil P Patel
AuditorMukesh M Shah & Co
Investor Email[email protected]
🌐 www.zyduswellness.com ↗

📍 Zydus Corporate Park S No 536, Sarkhej-Gandhinagar Highway, Ahmedabad, Gujarat, 382481

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Zota Health Care LimitedSaraswati Comm (India) LimitedZ-Tech India LimitedZuari Agro Chemicals Ltd.Zuari Industries LimitedZydus Lifesciences Ltd.All “Z” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search